Guidelines for the Management of Sexually Transmitted Infections. February 2004
(2004; 88 pages)
Table of Contents
View the documentPREFACE
Open this folder and view contents1. INTRODUCTION
Open this folder and view contents2. TREATMENT OF STI-ASSOCIATED SYNDROMES
Close this folder3. TREATMENT OF SPECIFIC INFECTIONS
Open this folder and view contents3.1. Gonococcal infections
Open this folder and view contents3.2. Chlamydia trachomatis infections (other than lymphogranuloma venereum)
View the document3.3. Lymphogranuloma venereum
Open this folder and view contents3.4. Syphilis
View the document3.5. Chancroid
View the document3.6. Granuloma inguinale (Donovanosis)
Close this folder3.7. Genital herpes infections
View the documentFirst clinical episode
View the documentRecurrent infections
View the documentSuppressive therapy
View the documentHerpes in pregnancy
View the documentHerpes and HIV co-infection
Open this folder and view contents3.8. Venereal warts
View the document3.9. Trichomonas vaginalis infections
Open this folder and view contents3.10. Bacterial vaginosis
Open this folder and view contents3.11. Candidiasis
View the document3.12. Scabies
View the document3.13. Phthiriasis (pediculosis pubis)
Open this folder and view contents4. KEY CONSIDERATIONS UNDERLYING TREATMENTS
Open this folder and view contents5. PRACTICAL CONSIDERATIONS IN STI CASE MANAGEMENT
Open this folder and view contents6. CHILDREN6, ADOLESCENTS AND SEXUALLY TRANSMITTED INFECTIONS
View the documentANNEX. LIST OF PARTICIPANTS
 

First clinical episode

Recommended regimen

• acyclovir, 200mg orally, 5 times daily for 7 days.

OR

• acyclovir, 400mg orally, 3 times daily for 7 days

OR

• famciclovir, 250mg, 3 times daily for 7 days

OR

• valaciclovir, 1g, 2 times daily for 7 days

Treatment can be expected to reduce the formation of new lesions, the duration of pain, the time required for healing, and viral shedding. However, it does not appear to influence the natural history of recurrent disease.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019